Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.1.1.18 (
glutaminyl-tRNA synthetase
)
231
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human
glutaminyl-tRNA synthetase
is three times larger than the corresponding bacterial and twice as large as the yeast enzyme. It is possible that the additional sequences of the human
glutaminyl-tRNA synthetase
are required for the formation of the multienzyme complex which is known to include several of aminoacyl-
tRNA
synthetases in mammalian cells. To address this point we prepared antibodies against three regions of the human
glutaminyl-tRNA synthetase
, namely against its enzymatically important core region, and against two sections in its large C-terminal extension. In intact multienzyme complexes the core region was accessible to specific antibody binding. However, the C-terminal sections became available to specific antibody binding only when certain components of the multienzyme complex were either absent or degraded. These findings allow first conclusions as to the relative position of some components in the mammalian aminoacyl-
tRNA
synthetase complex.
...
PMID:Glutaminyl-tRNA synthetase as a component of the high-molecular weight complex of human aminoacyl-tRNA synthetases. An immunological study. 222 84
We have used a cDNA encoding the core region of the human
glutaminyl-tRNA synthetase
to determine the chromosomal localization of the corresponding gene. Southern blots of restricted DNA from a panel of rodent-human cell lines and in situ chromosome hybridization gave identical results showing that the human gene locus for
glutaminyl-tRNA synthetase
resides on the distal long arm of chromosome 1. There are now nine mapped aminoacyl-
tRNA
synthetase genes in the human genome.
...
PMID:The human QARS locus: assignment of the human gene for glutaminyl-tRNA synthetase to chromosome 1q32-42. 222 38
We show that the amber termination codon UAG can initiate protein synthesis in Escherichia coli. We mutated the initiation codon AUG of the chloramphenicol acetyltransferase (CAT) gene to UAG (CATam1) and translated mRNA derived from the mutant CAT gene in E. coli S-30 extracts. A full-length CAT polypeptide was synthesized in the presence of
tRNA
(fMetCUA), a mutant E. coli initiator
tRNA
which has a change in the anticodon sequence from CAU to CUA. Addition of purified E. coli
glutaminyl-tRNA synthetase
substantially stimulated synthesis of the CAT polypeptide. Thus, initiation of protein synthesis with UAG and
tRNA
(fMetCUA) most likely occurs with glutamine and not methionine. The UAG codon also initiates protein synthesis in vivo. To eliminate a weak secondary site of initiation from AUC, the fifth codon, we further mutagenized the CATam1 gene at codons 2 (GAG----GAC) and 5 (AUC----ACC). Transformation of E. coli with the resultant CATam1.2.5 gene yielded transformants that synthesized CAT polypeptide and were resistant to chloramphenicol only when they were also transformed with the mutant
tRNA
(fMetCUA) gene. Immunoblot analyses and assays for CAT enzyme activity in extracts from transformed cells indicate that initiation from UAG is efficient, 60-70% of that obtained from AUG. Initiation of protein synthesis from UAG using a mutant initiator
tRNA
allows tightly regulated expression of specific genes. This may be generally useful for overproduction in E. coli and other eubacteria of proteins which are toxic to these cells.
...
PMID:Initiation of protein synthesis from a termination codon. 240 24
In previous publications, we have shown that it is practical to study the translational activity of tRNAs by replacement and alteration of the anticodon arm sequence of the genus on a plasmid clone. Experiments in which the anticodon arm sequence is transplanted between
tRNA
genes suggest that the translational activity is determined by these sequences. We have therefore made every variant of the anticodon loop and the three base-pairs of the stem proximal to the loop, in order to resolve the relation between the structure of Su7Am tRNATrp, and its function. All derivatives conserved the normal secondary structure of the molecule, which was known to be essential for translational activity. The probability of translation of the amber codon by these suppressors is measured in this work. This translational activity in vivo is rationalized in terms of data on the copy numbers of the plasmid clones, the nucleotide modifications of the tRNAs, the steady-state level of the mature
tRNA
, and the aminoacylation of these molecules. Nucleotide modification levels vary among these tRNAs, giving information about the specificities of modification systems that make O-methylribose, pseudouridine, and modified A in the anticodon arm. However, for this series of tRNAs, none of these modifications has a strong effect on translational efficiency of the tRNAs. A few of the substitutions reduce aminoacylation of the tRNAs with glutamine, as determined by comparison of suppression in normal strains and related strains, which have 25-fold elevated levels of the
glutaminyl-tRNA synthetase
(
GlnRS
). The substitutions that have the largest effect on
GlnRS
action are, unexpectedly, purines for conserved pyrimidines on the 5' side of the anticodon loop. Data on the concentrations of
tRNA
in vivo suggest that the anticodon loop and helix contribute similarly to the determination of the steady-state level of the tRNAs. This level varies sevenfold, though all tRNAs are processed from a homologous precursor made from the same transcription unit. Effects on levels appear to be mediated by changes in anticodon arm structure. A robust equation that relates aminoacyl-
tRNA
levels to suppressor efficiency is developed in order to resolve effects on
tRNA
levels and on ribosomal steps: E = A/(K + A), where E is efficiency, A is aminoacyl-
tRNA
concentration, and K is the effective concentration, or cellular
tRNA
content required for an individual
tRNA
to have an efficiency of 0.50. The tRNAs vary in their intrinsic ability to function on the ribosome (represented by K), after other influences have been normalized.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Actions of the anticodon arm in translation on the phenotypes of RNA mutants. 243 16
Five aminoacyl-
tRNA
synthetases found in the high molecular weight core complex were phosphorylated in rabbit reticulocytes following labeling with 32P. The synthetases were isolated by affinity chromatography on
tRNA
-Sepharose followed by immunoprecipitation. The five synthetases phosphorylated were the glutamyl-, glutaminyl-, lysyl-, and aspartyl-
tRNA
synthetases and, to a lesser extent, the methionyl-tRNA synthetase. In addition, a 37,000-dalton protein, associated with the synthetase complex and tentatively identified as casein kinase I, was also phosphorylated in intact cells. Phosphoamino acid analysis of the proteins indicated all of the phosphate was on seryl residues. Incubation of reticulocytes with 32P in the presence of 8-bromo-cAMP and 3-isobutyl-1-methylxanthine resulted in a 6-fold increase in phosphorylation of the
glutaminyl-tRNA synthetase
and a 2-fold increase in phosphorylation of the aspartyl-tRNA synthetase. When the high molecular weight core complex was isolated by gel filtration/affinity chromatography, the profile of phosphorylation was similar to that observed by immunoprecipitation with a 9- and 3-fold stimulation of the glutaminyl- and aspartyl
tRNA
-synthetase, respectively. From this data it was concluded that the increased phosphorylation of the glutaminyl- and aspartyl-
tRNA
synthetases obtained with 8-bromo-cAMP did not appear to be involved in dissociation of the high molecular weight core complex.
...
PMID:Regulation of phosphorylation of aminoacyl-tRNA synthetases in the high molecular weight core complex in reticulocytes. 243 10
We describe the genetically engineered overproduction of Escherichia coli
tRNA
(2Gln), its purification by high pressure liquid chromatography (HPLC), and its subsequent use in the growth of crystals of the E. coli
glutaminyl-tRNA synthetase
-
tRNA
(Gln) complex. The overproduced
tRNA
represents 60 to 70% of the total
tRNA
extracted from the engineered strain. A single anion exchange HPLC column is then sufficient to increase the purity of this isoacceptor to 90 to 95%. Crystals of this material complexed with the monomeric E. coli
glutaminyl-tRNA synthetase
enzyme were obtained by vapor diffusion from solutions containing sodium citrate as the precipitating agent. The crystals diffract to beyond 2.8 A resolution (1 A = 0.1 nm) and are of the orthorhombic space group C222(1) with unit cell parameters a = 240.5 A, b = 93.9 A, c = 115.7 A. Gel electrophoresis of dissolved crystals demonstrates the presence of both protein and
tRNA
.
...
PMID:Overproduction and purification of Escherichia coli tRNA(2Gln) and its use in crystallization of the glutaminyl-tRNA synthetase-tRNA(Gln) complex. 245 91
We described previously the isolation, by genetic selection, of a mutant of Escherichia coli
glutaminyl-tRNA synthetase
that misaminoacylates supFtRNATyr with glutamine. The single amino acid change responsible for the mischarging phenotype was identified at amino acid 235 in the translated glnS gene. The mutant, called glnS7, has an Asp----Asn change, and studies with the purified glnS7 gene product show it may mischarge a number of presumably different tRNAs. We have carried out extensive homology searches that show E. coli
glutaminyl-tRNA synthetase
shares regions of homology with other aminoacyl-
tRNA
synthetases, although little apparent similarity at the site of the glnS7 mutation. In addition to the conserved 'HIGH' motif implicated in aminoacyl adenylate formation, there are regions of homology of
glutaminyl-tRNA synthetase
with other synthetases which may be involved in
tRNA
binding. These include short stretches of homology in sequences acting as a
tRNA
'anchor' as well as homology of some aminoacyl-
tRNA
synthetases to a recently identified motif in ribonucleoproteins. Therefore, our results show that E. coli
glutaminyl-tRNA synthetase
may share with other aminoacyl-
tRNA
synthetases regions responsible for
tRNA
binding, while other regions of the protein, of which the glnS7 mutation may be a component, are responsible for
tRNA
discrimination.
...
PMID:Escherichia coli glutaminyl-tRNA synthetase: a single amino acid replacement relaxes rRNA specificity. 246 70
The crystal structure of Escherichia coli
glutaminyl-tRNA synthetase
(
GlnRS
) complexed with its cognate glutaminyl transfer RNA (
tRNA
(Gln] and adenosine triphosphate (ATP) has been derived from a 2.8 angstrom resolution electron density map and the known protein and
tRNA
sequences. The 63.4-kilodalton monomeric enzyme consists of four domains arranged to give an elongated molecule with an axial ratio greater than 3 to 1. Its interactions with the
tRNA
extend from the anticodon to the acceptor stem along the entire inside of the L of the
tRNA
. The complexed
tRNA
retains the overall conformation of the yeast phenylalanine
tRNA
(
tRNA
(Phe] with two major differences: the 3' acceptor strand of
tRNA
(Gln) makes a hairpin turn toward the inside of the L, with the disruption of the final base pair of the acceptor stem, and the anticodon loop adopts a conformation not seen in any of the previously determined
tRNA
structures. Specific recognition elements identified so far include (i) enzyme contacts with the 2-amino groups of guanine via the
tRNA
minor groove in the acceptor stem at G2 and G3; (ii) interactions between the enzyme and the anticodon nucleotides; and (iii) the ability of the nucleotides G73 and U1.A72 of the cognate
tRNA
to assume a conformation stabilized by the protein at a lower free energy cost than noncognate sequences. The central domain of this synthetase binds ATP, glutamine, and the acceptor end of the
tRNA
as well as making specific interactions with the acceptor stem.2+t is
...
PMID:Structure of E. coli glutaminyl-tRNA synthetase complexed with tRNA(Gln) and ATP at 2.8 A resolution. 247 81
In Escherichia coli K-12, the heat shock protein DnaK and DnaJ participate in phosphorylation of both
glutaminyl-tRNA synthetase
and threonyl-tRNA synthetase since when cellular proteins extracted from the dnaK7(Ts), dnaK756(Ts) and dnaJ259(Ts) mutant cells labeled with 32Pi at 42 degrees C were analyzed by two-dimensional gel electrophoresis, no phosphorylation of
glutaminyl-tRNA synthetase
and threonyl-tRNA synthetase was observed while phosphorylation of both aminoacyl-
tRNA
synthetases was detected in the samples extracted from wild-type cells.
...
PMID:Phosphorylation of glutaminyl-tRNA synthetase and threonyl-tRNA synthetase by the gene products of dnaK and dnaJ in Escherichia coli K-12 cells. 251 99
The absence of a Watson-Crick base pair at the end of the amino acid acceptor stem is one of the features which distinguishes prokaryotic initiator tRNAs as a class from all other tRNAs. We show that this structural feature prevents Escherichia coli initiator
tRNA
from acting as an elongator in protein synthesis in vivo. We generated a mutant of E. coli initiator
tRNA
in which the anticodon sequence is changed from CAU to CUA (the T35A36 mutant). This mutant
tRNA
has the potential to read the amber termination codon UAG. We then coupled this mutation to others which change the C1.A72 mismatch at the end of the acceptor stem to either a U1:A72 base pair (T1 mutant) or a C1:G72 base pair (G72 mutant). Transformation of E. coli CA274 (HfrC Su- lacZ125am trpEam) with multicopy plasmids carrying the mutant initiator
tRNA
genes show that mutant tRNAs carrying changes in both the anticodon sequence and the acceptor stem suppress amber codons in vivo, whereas mutant
tRNA
with changes in the anticodon sequence alone does not. Mutant tRNAs with the above anticodon sequence change are aminoacylated with glutamine in vitro. Measurement of kinetic parameters for aminoacylation by E. coli
glutaminyl-tRNA synthetase
show that both the nature of the base pair at the end of the acceptor stem and the presence or absence of a base pair at this position can affect aminoacylation kinetics. We discuss the implications of this result on recognition of tRNAs by E. coli
glutaminyl-tRNA synthetase
.
...
PMID:Suppression of amber codons in vivo as evidence that mutants derived from Escherichia coli initiator tRNA can act at the step of elongation in protein synthesis. 264 2
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>